National HealthCare Corporation
NHC · AMEX
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.65 | 0.03 | -0.79 | 0.19 |
| FCF Yield | 3.18% | 2.31% | 0.28% | 1.47% |
| EV / EBITDA | 37.99 | 30.38 | 90.56 | 29.62 |
| Quality | ||||
| ROIC | 1.92% | 1.68% | 1.99% | 1.14% |
| Gross Margin | 39.77% | 38.95% | 36.56% | 37.27% |
| Cash Conversion Ratio | 1.61 | 2.61 | 1.22 | 2.12 |
| Growth | ||||
| Revenue 3-Year CAGR | 10.75% | 10.29% | 8.52% | 6.51% |
| Free Cash Flow Growth | 58.87% | 614.83% | -83.77% | -33.34% |
| Safety | ||||
| Net Debt / EBITDA | 1.36 | 2.21 | 6.99 | 2.08 |
| Interest Coverage | 0.00 | 14.61 | 11.32 | 12.08 |
| Efficiency | ||||
| Inventory Turnover | 28.70 | 28.24 | 25.92 | 27.22 |
| Cash Conversion Cycle | 28.95 | 28.91 | 26.78 | 27.95 |